Molecular Tumor Board
Molecular Tumor Board
Since 2020, the Molecular Tumor Board (MTB) is a board with a strong multidisciplinary focus, integrating the knowledge and experience of professionals from different fields. It aims to harmonize the access to molecular analyses and help oncologists in the choice of appropriate therapies which take into account the clinical context and tumor biology. The MTB deals with the identification of patients eligible for molecular testing of the most suitable and cost-effective panel of genes. It also deals with the interpretation of data from molecular analysis in order to define the biological meaning and therapeutic actionability of the genetic abnormalities for the identification of potentially active drugs, and discussed patients’ clinical-genomic data to define the optimal treatment.